Search Results
Targeting AML with multimodal immunotherapeutic approaches
A Master Class on Building Better Therapy for AML
How Will AML Treatment Evolve?
Boosting Immune Defenses Against Cancer, with Philip D. Greenberg
How can we overcome ibrutinib resistance?
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
The HCC Treatment Algorithm: New and Emerging Monotherapy, Combination, and Multimodal Approaches
Dr. Philipp Altrock - Quantifying CAR T cells activity against AML
What Are Current Myeloma Treatment Approaches?
Alex Huang, MD, PhD - UH Research & Education Institute 3rd Research & Innovation Day
Maximizing the Potential of Immunotherapy in Unresectable Stage III NSCLC
Strategies to Enhance the Efficacy of CAR T Cells
